Field and laboratory perspectives on fentanyl and carfentanil decontamination.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 Oct 2024
Historique:
received: 23 07 2024
accepted: 27 09 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Abuse of the highly toxic compound fentanyl and its analogues is increasing, raising serious public health concerns due to their potency and availability. Therefore, there is a need for decontamination methodologies to safely remove fentanyl to avoid harmful exposure. In this study, the efficacy of commercial and in-house synthesized decontamination agents (Dahlgren Decon, RSDL (Reactive Skin Decontamination Lotion), FAST-ACT (First applied sorbent treatment against chemical threats), GDS2000, alldecont MED, bleach, Domestos Spray Bleach, Effekt Klor, MgO, TiO

Identifiants

pubmed: 39455665
doi: 10.1038/s41598-024-74594-z
pii: 10.1038/s41598-024-74594-z
doi:

Substances chimiques

Fentanyl UF599785JZ
carfentanil LA9DTA2L8F
Analgesics, Opioid 0
Receptors, Opioid, mu 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25381

Subventions

Organisme : The collaborative international consortium GreenWaterTech financed under the ERA-NET AquaticPollutants Joint Transnational Call
ID : 869178
Organisme : The collaborative international consortium GreenWaterTech financed under the ERA-NET AquaticPollutants Joint Transnational Call
ID : 869178

Informations de copyright

© 2024. The Author(s).

Références

Stanley, T. H. The fentanyl story. J. Pain. 15, 1215–1226 (2014).
pubmed: 25441689 doi: 10.1016/j.jpain.2014.08.010
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M. & Tracy, D. K. Synthetic opioids: a review and clinical update. Therapeutic Adv. Psychopharmacol.12, 20451253221139616 (2022).
doi: 10.1177/20451253221139616
Jannetto, P. J. et al. The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European Union. Clin. Chem.65, 242–253 (2019).
pubmed: 30305277 doi: 10.1373/clinchem.2017.281626
Burns, S. M., Cunningham, C. W. & Mercer, S. L. DARK classics in chemical neuroscience: fentanyl. ACS Chem. Neurosci.9, 2428–2437 (2018).
pubmed: 29894151 doi: 10.1021/acschemneuro.8b00174
Patocka, J. et al. Fentanyl and its derivatives: Pain-killers or man-killers? Heliyon. 10, e28795 (2024).
pubmed: 38644874 pmcid: 11031787 doi: 10.1016/j.heliyon.2024.e28795
Gardner, E. A., McGrath, S. A., Dowling, D. & Bai, D. The opioid crisis: prevalence and markets of opioids. Forensic Sci. Rev.34, 43–70 (2022).
pubmed: 35105535
Pierce, M., van Amsterdam, J., Kalkman, G. A., Schellekens, A. & van den Brink, W. Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur. Psychiatry. 64, e47 (2021).
pubmed: 34165059 pmcid: 8316471 doi: 10.1192/j.eurpsy.2021.2219
Zawilska, J., Kuczynska, K., Kosmal, W., Markiewicz, K. & Adamowicz, P. Carfentanil-from an animal anesthetic to a deadly illicit drug. Forensic Sci. Int.320, 110715 (2021).
pubmed: 33581655 doi: 10.1016/j.forsciint.2021.110715
Ringuette, A. E., Spock, M., Lindsley, C. W. & Bender A. M. DARK classics in chemical neuroscience: carfentanil. ACS Chem. Neurosci.11, 3955–3967 (2020).
pubmed: 32786301 doi: 10.1021/acschemneuro.0c00441
Thomas, A. R. & Schwartz, R. M. At-risk populations to unintentional and intentional fentanyl and fentanyl + exposure. J. Transp. Secur.12, 73–82 (2019).
doi: 10.1007/s12198-019-00202-1
Dalton, C., Watkins, R., Pritchard, S. & Graham, S. Skin decontamination of carfentanil in vitro. Toxicol. Lett.388, 56–63 (2023).
pubmed: 37806367 doi: 10.1016/j.toxlet.2023.10.005
de Bruin-Hoegée, M., de Koning, M. C., Cochrane, L. & Joosen, M. J. Contact transfer risk from fentanyl-contaminated RSDL
pubmed: 31738974 doi: 10.1016/j.toxlet.2019.11.013
Thors, L. et al. Skin penetration and decontamination efficacy following human skin exposure to fentanyl. Toxicol. In Vitro. 67, 104914 (2020).
pubmed: 32540164 doi: 10.1016/j.tiv.2020.104914
Cibulsky, S. M. et al. Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids. Front. Public. Health. 11, 1158479 (2023).
pubmed: 37250077 pmcid: 10213671 doi: 10.3389/fpubh.2023.1158479
Basham, C. et al. Occupational safety and health and illicit opioids: state of the research on protecting against the threat of occupational exposure. NEW. SOLUTIONS: J. Environ. Occup. Health Policy. 31, 315–329 (2021).
doi: 10.1177/10482911211039566
Bazley, M. M., Logan, M., Baxter, C., Robertson, A. A. B. & Blanchfield, J. T. Decontamination of fentanyl and fentanyl analogues in field and laboratory settings: a review of fentanyl degradation. Aust. J. Chem.73, 868–879 (2020).
Qi, L., Cheng, Z., Zuo, G., Li, S. & Fan, Q. Oxidative degradation of fentanyl in aqueous solutions of peroxides and hypochlorites. Def. Sci. J.61, 30–35 (2011).
doi: 10.14429/dsj.61.68
Garg, A., Solas, D. W., Takahashi, L. H. & Cassella, J. V. Forced degradation of fentanyl: identification and analysis of impurities and degradants. J. Pharm. Biomed. Anal.53, 325–334 (2010).
pubmed: 20462721 doi: 10.1016/j.jpba.2010.04.004
Manral, L., Gupta, P., Suryanarayana, M., Ganesan, K. & Malhotra, R. Thermal behaviour of fentanyl and its analogues during flash pyrolysis. J. Therm. Anal. Calorim.96, 531–534 (2009).
doi: 10.1007/s10973-008-9211-z
Xu, L. et al. Oxidative treatment of fentanyl compounds in water by sodium bromate combined with sodium sulphite. Water Sci. Technol.72, 38–44 (2015).
pubmed: 26114269 doi: 10.2166/wst.2015.185
Froelich, N. M., Sprague, J. E. & Worst, T. J. Letter to the editor — elbow grease and OxiClean™ for cleaning fentanyl- and acetylfentanyl-contaminated surfaces. J. Forensic Sci.63, 336–338 (2018).
pubmed: 29314013 doi: 10.1111/1556-4029.13675
Durnal, E., Kelsey, P. & Sam, H. First Line Technology, LLC. Dahlgren Decontamination Studies, Final Project Report R1 (First Line Technology, LLC, Chantilly, 2018).
DahlgrenDecon Datasheet. ( https://www.epequip.com/wp-content/uploads/2020/03/DahlgrenDecon_Datasheet_07062016_EPE-Branded-compressed.pdf ).
Sisco, E., Najarro, M. & Burns, A. Quantifying the effectiveness of cleaning agents at removing drugs from laboratory benches and floor tiles. Forensic Chem.12, 1–7 (2019).
doi: 10.1016/j.forc.2018.11.002
Oudejans, L., See, D., Dodds, C., Corlew, M. & Magnuson, M. Decontamination options for indoor surfaces contaminated with realistic fentanyl preparations. J. Environ. Manage.297, 113327 (2021).
pubmed: 34311256 pmcid: 8573902 doi: 10.1016/j.jenvman.2021.113327
Vol. Version 1.0 05/22/2018 (Environmental Protection Agency, Washington, DC, U.S., Available online at: (2018). https://www.epa.gov/emergency-response/fact-sheet-fentanyl-and-fentanyl-analogs .
Langmaier, J. et al. Ion transfer voltammetric and LC/MS investigations of the oxidative degradation process of fentanyl and some of its structural analogs. Electrochim. Acta. 441, 141848 (2023).
doi: 10.1016/j.electacta.2023.141848
Lambropoulos, J., Spanos, G. A., Lazaridis, N. V., Ingallinera, T. S. & Rodriguez, V. K. Development and validation of an HPLC assay for fentanyl and related substances in fentanyl citrate injection, USP. J. Pharm. Biomed. Anal.20, 705–716 (1999).
pubmed: 10704140 doi: 10.1016/S0731-7085(99)00077-1
Verheij, E. R., Joosen, M. J. A., Cochrane, L., de Bruin-Hoegee, M. & de Koning, M. C. Decontamination of toxic industrial chemicals and fentanyl by application of the RSDL
doi: 10.55460/COFJ-WMPA
Henych, J. et al. Reactive adsorption and photodegradation of soman and dimethyl methylphosphonate on TiO2/nanodiamond composites. Appl. Catal. B. 259, 118097 (2019).
doi: 10.1016/j.apcatb.2019.118097
Love, A. H. et al. Efficacy of liquid and foam decontamination technologies for chemical warfare agents on indoor surfaces. J. Hazard. Mater.196, 115–122 (2011).
pubmed: 21944706 doi: 10.1016/j.jhazmat.2011.09.005
Feasel, M. et al. Metabolism of carfentanil, an ultra-potent opioid, in human liver microsomes and human hepatocytes by high-resolution mass spectrometry. AAPS J.18, 1489–1499 (2016).
pubmed: 27495118 doi: 10.1208/s12248-016-9963-5
Safetey Data Sheet. (2010). www.clasohlson.com/medias/sys_master/9542894682142.pdf .
Safetey Data Sheet ( https://images2.europris.no/dokumenter/188761/188761.pdf , 2015)
Mörén, L. et al. Rapid screening of riot control agents using DART-TD-HRMS. Forensic. Toxicol. s11419 (2024).
Brown, H., Oktem, B., Windom, A., Doroshenko, V. & Evans-Nguyen, K. Direct analysis in real time (DART) and a portable mass spectrometer for rapid identification of common and designer drugs on-site. Forensic Chem.1, 66–73 (2016).
doi: 10.1016/j.forc.2016.07.002
Sisco, E., Forbes, T. P., Staymates, M. E. & Gillen, G. Rapid analysis of trace drugs and metabolites using a thermal desorption DART-MS configuration. Anal. Methods. 8, 6494–6499 (2016).
pubmed: 28630654 pmcid: 5473286 doi: 10.1039/C6AY01851C
Cooman, T. et al. Screening of seized drugs utilizing portable Raman spectroscopy and direct analysis in real time-mass spectrometry (DART-MS). Forensic Chem.25, 100352 (2021).
doi: 10.1016/j.forc.2021.100352
Pasternak, G. W. & Pan, Y. X. Mu opioids and their receptors: evolution of a concept. Pharmacol. Rev.65, 1257–1317 (2013).
pubmed: 24076545 pmcid: 3799236 doi: 10.1124/pr.112.007138
Langston, J. L., Moffett, M. C., Makar, J. R., Burgan, B. M. & Myers, T. M. Carfentanil toxicity in the African green monkey: therapeutic efficacy of naloxone. Toxicol. Lett.325, 34–42 (2020).
pubmed: 32070766 doi: 10.1016/j.toxlet.2020.02.008
Hsu, F. L. et al. Synthesis and µ-opioid activity of the primary metabolites of carfentanil. ACS Med. Chem. Lett.10, 1568–1572 (2019).
pubmed: 31749912 pmcid: 6862335 doi: 10.1021/acsmedchemlett.9b00404
Bird, H. E., Huhn, A. S. & Dunn, K. E. Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl. J. Addicttion Med.17, 503–508 (2023).
doi: 10.1097/ADM.0000000000001185
Adams, A. P. & Pybus, D. A. Delayed respiratory depression after use of fentanyl during anaesthesia. Brittish Med. J.4, 278–279 (1978).
doi: 10.1136/bmj.1.6108.278
Dalton, C., Watkins, R., Pritchard, S. & Graham, S. Percutaneous absorption of Carfentanil in vitro. Toxicol. Vitro. 72, 105100 (2021).
doi: 10.1016/j.tiv.2021.105100
Mörén, L. et al. Attribution of fentanyl analogue synthesis routes by multivariate data analysis of orthogonal mass spectral data. Talanta. 203, 122–130 (2019).
pubmed: 31202316 doi: 10.1016/j.talanta.2019.05.025
Aggarwal, V. K., Gültekin, Z., Grainger, R. S., Adams, H. & Spargo, P. L. 1R, 3R)-2-Methylene-1, 3-dithiolane 1, 3-dioxide: a highly reactive and highly selective chiral ketene equivalent in cycloaddition reactions with a broad range of dienes. J. Chem. Soc. Perkin Trans.1, 2771–2782 (1998).
doi: 10.1039/a804607g
Ederer, J., Šťastný, M., Došek, M., Henych, J. & Janoš, P. Mesoporous cerium oxide for fast degradation of aryl organophosphate flame retardant triphenyl phosphate. RSC Adv.9, 32058–32065 (2019).
pubmed: 35530782 pmcid: 9072973 doi: 10.1039/C9RA06575J
Lave, T. et al. The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans. Pharm. Res.14, 152–155 (1997).
pubmed: 9090701 doi: 10.1023/A:1012036324237
Lau, Y. Y. et al. The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios. Pharm. Res.19, 1606–1610 (2002).
pubmed: 12458665 doi: 10.1023/A:1020765025857

Auteurs

Pernilla Lindén (P)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Lina Mörén (L)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Johanna Qvarnström (J)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Nina Forsgren (N)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Cecilia Springer Engdahl (CS)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Magnus Engqvist (M)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Jiri Henych (J)

Institute of Inorganic Chemistry of the Czech Academy of Sciences, Husinec-Řež, 250 68, Czech Republic.

Tobias Tengel (T)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Lars Österlund (L)

Department of Materials Science and Engineering, The Ångström Laboratory, Uppsala University, P. O. Box 35, Uppsala, SE-75103, Sweden.

Lina Thors (L)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Andreas Larsson (A)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden.

Susanne Johansson (S)

Swedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, 901 82, Sweden. susanne.johansson@foi.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH